Kyle A. Furge

5.5k citations

55 papers · 3.8k indexed · h-index 33

Molecular Biology top 2%
Pulmonary and Respiratory Medicine top 2%
Cancer Research top 1%
Oncology top 5%
Cell Biology top 5%

Co-authors: Bin Tean Teh George F. Vande Woude Karl Dykema Richard J. Kahnoski David Petillo Ximing J. Yang Charles F. Albright Masayuki Takahashi
Topics: Renal cell carcinoma treatment (20 papers)Renal and related cancers (14 papers)Cancer Genomics and Diagnostics (13 papers)
Cited by: Cancer Research Molecular Biology Hepatology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Nature Medicine
Partner nations: United States Singapore Canada

In The Last Decade

Kyle A. Furge

55 papers receiving 3.7k citations

Peers

Countries citing papers authored by Kyle A. Furge

Since Specialization

Citations

This map shows the geographic impact of Kyle A. Furge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle A. Furge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle A. Furge more than expected).

Fields of papers citing papers by Kyle A. Furge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle A. Furge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle A. Furge. The network helps show where Kyle A. Furge may publish in the future.

Co-authorship network of co-authors of Kyle A. Furge

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle A. Furge. A scholar is included among the top collaborators of Kyle A. Furge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle A. Furge. Kyle A. Furge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tryptophan-75 Is a Low-Energy Channel-Gating Residue that Facilitates Substrate Egress/Access in Cytochrome P450 2D6 2020 ·Drug Metabolism and Disposition ·(unknown),(unknown),Kyle A. Furge,Laura Lowe Furge	2
2	Pharmacologic Inhibition of MEK Signaling Prevents Growth of Canine Hemangiosarcoma 2013 ·Molecular Cancer Therapeutics ·(unknown),Brian J. Nickoloff,Karl Dykema,Elissa A. Boguslawski,(unknown),(unknown),(unknown),Laurence H. Baker,Dafydd G. Thomas,Debra A. Kamstock,Barbara E. Kitchell,Kyle A. Furge,Nicholas S. Duesbery	21
3	CUL3 and NRF2 Mutations Confer an NRF2 Activation Phenotype in a Sporadic Form of Papillary Renal Cell Carcinoma 2013 ·Cancer Research ·Aikseng Ooi,Karl Dykema,Asif Ansari,David Petillo,John Snider,Richard J. Kahnoski,John Anema,David W. Craig,John D. Carpten,Bin Tean Teh,Kyle A. Furge	121
4	Expression of the PTTG1 Oncogene Is Associated with Aggressive Clear Cell Renal Cell Carcinoma 2012 ·Cancer Research ·Bill Wondergem,Zhongfa Zhang,Dachuan Huang,Choon Kiat Ong,Julie Koeman,(unknown),David Petillo,Aikseng Ooi,John Anema,Brian R. Lane,Richard J. Kahnoski,Kyle A. Furge,Bin Tean Teh	45
5	Cancer-Type Regulation of MIG-6 Expression by Inhibitors of Methylation and Histone Deacetylation 2012 ·PLoS ONE ·Yuwen Zhang,Ben Staal,Karl Dykema,Kyle A. Furge,George F. Vande Woude	16
6	Combined Gene Expression Profiling and RNAi Screening in Clear Cell Renal Cell Carcinoma Identify PLK1 and Other Therapeutic Kinase Targets 2011 ·Cancer Research ·Yan Ding,Dan Huang,Zhongfa Zhang,(unknown),David Petillo,Brendan D. Looyenga,Kristin Feenstra,Jeffrey P. MacKeigan,Kyle A. Furge,Bin Tean Teh	31
7	Deregulation of E2-EPF Ubiquitin Carrier Protein in Papillary Renal Cell Carcinoma 2011 ·American Journal Of Pathology ·Frederik C. Roos,Andrew Evans,Walburgis Brenner,Bill Wondergem,(unknown),Pardeep Heir,O. Roche,Christian Thomas,(unknown),Kyle A. Furge,Bin Tean Teh,Joachim W. Thüroff,Christian Hampel,Michael Ohh	35
8	Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma 2010 ·Cancer Research ·Dan Huang,Yan Ding,Ming Zhou,Brian I. Rini,David Petillo,Chao-Nan Qian,Richard J. Kahnoski,P. Andrew Futreal,Kyle A. Furge,Bin Tean Teh	330
9	Genetic and Structural Variation in the Gastric Cancer Kinome Revealed through Targeted Deep Sequencing 2010 ·Cancer Research ·Zhi Jiang Zang,Choon Kiat Ong,Ioana Cutcutache,Willie Yu,Shen Li Zhang,Dachuan Huang,Lian Dee Ler,Karl Dykema,Anna Gan,Jiong Tao,(unknown),Yujing Liu,P. Andrew Futreal,Heike I. Grabsch,Kyle A. Furge,Liang Kee Goh,Steve Rozen,Bin Tean Teh,Patrick Tan	69
10	The Wnt Co-Receptor Lrp6 Is Required for Normal Mouse Mammary Gland Development 2009 ·PLoS ONE ·Charlotta Lindvall,Cassandra R. Zylstra,Nicole C. Evans,Richard West,Karl Dykema,Kyle A. Furge,Bart O. Williams	115
11	Regulation of endocytosis via the oxygen-sensing pathway 2009 ·Nature Medicine ·(unknown),O. Roche,(unknown),Greg Finak,Andrew Evans,Julie Metcalf,Bridgid E. Hast,Sara C. Hanna,Bill Wondergem,Kyle A. Furge,Meredith S. Irwin,William Y. Kim,Bin Tean Teh,Sergio Grinstein,Morag Park,Philip A. Marsden,Michael Ohh	160
12	Correction: Somatic Pairing of Chromosome 19 in Renal Oncocytoma Is Associated with Deregulated EGLN2-Mediated Oxygen-Sensing Response 2008 ·PLoS Genetics ·Julie Koeman,Ryan C. Russell,Min‐Han Tan,David Petillo,(unknown),(unknown),Julie Metcalf,Zhongfa Zhang,Daisuke Matsuda,Karl Dykema,(unknown),Eric J. Kort,(unknown),Richard J. Kahnoski,Annick Vieillefond,Pamela J. Swiatek,Bin Tean Teh,Michael Ohh,Kyle A. Furge	3
13	Detection of DNA Copy Number Changes and Oncogenic Signaling Abnormalities from Gene Expression Data Reveals MYC Activation in High-Grade Papillary Renal Cell Carcinoma 2007 ·Cancer Research ·Kyle A. Furge,Jindong Chen,Julie Koeman,Pamela J. Swiatek,Karl Dykema,(unknown),Richard J. Kahnoski,Ximing J. Yang,Bin Tean Teh	112
14	Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling 2007 ·Oncogene ·Kyle A. Furge,(unknown),Karl Dykema,Eric J. Kort,Walter M. Stadler,Xin Yao,Ming Zhou,Bin Tean Teh	35
15	Gene Expression Profiling in Kidney Cancer: Combining Differential Expression and Chromosomal and Pathway Analyses 2006 ·Clinical Genitourinary Cancer ·Kyle A. Furge,Eric J. Kort,Ximing J. Yang,Walter M. Stadler,Hyung L. Kim,Bin Tean Teh	3
16	Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma 2005 ·Carcinogenesis ·Mohini A. Patil,Ines Gütgemann,Ji Zhang,Coral Ho,ST Cheung,David G. Ginzinger,Rui Li,Karl Dykema,Samuel So,(unknown),Sanjay Kakar,Kyle A. Furge,Reinhard Büttner,Xin Chen	111
17	Comparison of array-based comparative genomic hybridization with gene expression-based regional expression biases to identify genetic abnormalities in hepatocellular carcinoma 2005 ·BMC Genomics ·Kyle A. Furge,Karl Dykema,Coral Ho,Xin Chen	33
18	Robust Classification of Renal Cell Carcinoma Based on Gene Expression Data and Predicted Cytogenetic Profiles 2004 ·Cancer Research ·Kyle A. Furge,(unknown),Masayuki Takahashi,Jun Sugimura,Eric J. Kort,Hiro-omi Kanayama,Susumu Kagawa,(unknown),John Curry,Ximing J. Yang,Bin Tean Teh	82
19	Diminished transcription of chromosome arm 4q is inversely related to local spreading of hepatocellular carcinoma 2004 ·Genes Chromosomes and Cancer ·Karl Dykema,Kyle A. Furge	5
20	Loss of Rhb1, a Rheb-Related GTPase in Fission Yeast, Causes Growth Arrest With a Terminal Phenotype Similar to That Caused by Nitrogen Starvation 2000 ·Genetics ·Kathleen E. Mach,Kyle A. Furge,Charles F. Albright	85

About Kyle A. Furge

Kyle A. Furge is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 55 papers that have together received 3.8k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (20 papers), Renal and related cancers (14 papers) and Cancer Genomics and Diagnostics (13 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (2.8k citations) and Hepatology (313 citations). Kyle A. Furge has collaborated with scholars based in United States, Singapore and Canada. Frequent co-authors include Bin Tean Teh, George F. Vande Woude, Karl Dykema, Richard J. Kahnoski, David Petillo, Ximing J. Yang, Charles F. Albright, Masayuki Takahashi, Susumu Kagawa and Hiro‐omi Kanayama. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact